Application 212297

Type
ANDA
Sponsor
BIOCON PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TACROLIMUSTACROLIMUSCAPSULE;ORALEQ 0.5MG BASENoNo
002TACROLIMUSTACROLIMUSCAPSULE;ORALEQ 1MG BASENoNo
003TACROLIMUSTACROLIMUSCAPSULE;ORALEQ 5MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55154-4080TacrolimusTacrolimusCardinal Health 107, LLCANDACurrent
55154-4080TacrolimusTacrolimusCardinal HealthANDACurrent
70377-014TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-014TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-014TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-015TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-015TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-015TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-016TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-016TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70377-016TacrolimusTacrolimusBiocon Pharma Inc.ANDACurrent
70518-2996TacrolimusTacrolimusREMEDYREPACK INC.ANDACurrent
70518-3022TacrolimusTacrolimusREMEDYREPACK INC.ANDACurrent